President Trump signed a memo on Tuesday directing the FDA to crack down on direct-to-consumer drug advertisements. But there are limits to what any administration can do.
Copyright 2025 NPR
Sydney Lupkin
Sydney Lupkin is the pharmaceuticals correspondent for NPR.